vs
ICU MEDICAL INC（ICUI）与印度钢铁管理局（SAIL）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是印度钢铁管理局的1.9倍（$540.7M vs $281.9M），ICU MEDICAL INC净利率更高（-2.9% vs -12.8%，领先9.8%），印度钢铁管理局同比增速更快（6.7% vs -14.1%），印度钢铁管理局自由现金流更多（$52.5M vs $36.0M）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
印度钢铁管理局（SAIL）是总部位于新德里的印度公营钢铁制造企业，属印度最高级别的“马哈拉特纳”中央公共部门企业，是印度最大的国有钢铁生产商，年钢铁产量达1829万吨，1973年1月24日成立，现有员工5.1万余名，由印度钢铁部行政管理。
ICUI vs SAIL — 直观对比
营收规模更大
ICUI
是对方的1.9倍
$281.9M
营收增速更快
SAIL
高出20.8%
-14.1%
净利率更高
ICUI
高出9.8%
-12.8%
自由现金流更多
SAIL
多$16.6M
$36.0M
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $281.9M |
| 净利润 | $-15.7M | $-36.0M |
| 毛利率 | 37.5% | 66.3% |
| 营业利润率 | 1.0% | -14.8% |
| 净利率 | -2.9% | -12.8% |
| 营收同比 | -14.1% | 6.7% |
| 净利润同比 | 34.0% | -240.9% |
| 每股收益（稀释后） | $-0.63 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUISAIL
| Q4 25 | $540.7M | $281.9M | ||
| Q3 25 | $537.0M | $264.4M | ||
| Q2 25 | $548.9M | $230.5M | ||
| Q1 25 | $604.7M | $240.1M | ||
| Q4 24 | $629.8M | — | ||
| Q3 24 | $589.1M | $198.6M | ||
| Q2 24 | $596.5M | $187.7M | ||
| Q1 24 | $566.7M | — |
净利润ICUISAIL
| Q4 25 | $-15.7M | $-36.0M | ||
| Q3 25 | $-3.4M | $-10.6M | ||
| Q2 25 | $35.3M | $-187.3M | ||
| Q1 25 | $-15.5M | $-80.1M | ||
| Q4 24 | $-23.8M | — | ||
| Q3 24 | $-33.0M | $-87.1M | ||
| Q2 24 | $-21.4M | $-89.2M | ||
| Q1 24 | $-39.5M | — |
毛利率ICUISAIL
| Q4 25 | 37.5% | 66.3% | ||
| Q3 25 | 37.4% | 67.3% | ||
| Q2 25 | 37.9% | 55.4% | ||
| Q1 25 | 34.7% | 66.5% | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 34.8% | 62.1% | ||
| Q2 24 | 34.8% | 61.5% | ||
| Q1 24 | 32.7% | — |
营业利润率ICUISAIL
| Q4 25 | 1.0% | -14.8% | ||
| Q3 25 | 2.6% | -15.4% | ||
| Q2 25 | 1.9% | -80.3% | ||
| Q1 25 | 2.1% | -12.6% | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 1.4% | -33.2% | ||
| Q2 24 | 1.3% | -36.3% | ||
| Q1 24 | -1.9% | — |
净利率ICUISAIL
| Q4 25 | -2.9% | -12.8% | ||
| Q3 25 | -0.6% | -4.0% | ||
| Q2 25 | 6.4% | -81.3% | ||
| Q1 25 | -2.6% | -33.4% | ||
| Q4 24 | -3.8% | — | ||
| Q3 24 | -5.6% | -43.9% | ||
| Q2 24 | -3.6% | -47.5% | ||
| Q1 24 | -7.0% | — |
每股收益（稀释后）ICUISAIL
| Q4 25 | $-0.63 | $-0.06 | ||
| Q3 25 | $-0.14 | $-0.02 | ||
| Q2 25 | $1.43 | $-0.42 | ||
| Q1 25 | $-0.63 | $-6.50 | ||
| Q4 24 | $-0.97 | — | ||
| Q3 24 | $-1.35 | $-2.97 | ||
| Q2 24 | $-0.88 | $-0.77 | ||
| Q1 24 | $-1.63 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $298.1M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $2.1B | $6.8B |
| 总资产 | $4.1B | $7.5B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ICUISAIL
| Q4 25 | — | $298.1M | ||
| Q3 25 | — | $271.1M | ||
| Q2 25 | — | $228.1M | ||
| Q1 25 | — | $121.3M | ||
| Q4 24 | $308.6M | — | ||
| Q3 24 | $312.5M | $89.7M | ||
| Q2 24 | $302.6M | $146.8M | ||
| Q1 24 | $251.4M | — |
总债务ICUISAIL
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ICUISAIL
| Q4 25 | $2.1B | $6.8B | ||
| Q3 25 | $2.1B | $6.8B | ||
| Q2 25 | $2.1B | $6.8B | ||
| Q1 25 | $2.0B | $-5.6B | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | $-701.3M | ||
| Q2 24 | $2.0B | $-622.5M | ||
| Q1 24 | $2.1B | — |
总资产ICUISAIL
| Q4 25 | $4.1B | $7.5B | ||
| Q3 25 | $4.1B | $7.4B | ||
| Q2 25 | $4.1B | $7.4B | ||
| Q1 25 | $4.2B | $7.4B | ||
| Q4 24 | $4.2B | — | ||
| Q3 24 | $4.3B | — | ||
| Q2 24 | $4.3B | — | ||
| Q1 24 | $4.3B | — |
负债/权益比ICUISAIL
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $53.6M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $52.5M |
| 自由现金流率自由现金流/营收 | 6.6% | 18.6% |
| 资本支出强度资本支出/营收 | 4.6% | 0.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.8M | — |
8季度趋势，按日历期对齐
经营现金流ICUISAIL
| Q4 25 | $60.6M | $53.6M | ||
| Q3 25 | $56.7M | $49.9M | ||
| Q2 25 | $11.2M | $-96.8M | ||
| Q1 25 | $51.3M | — | ||
| Q4 24 | $40.2M | — | ||
| Q3 24 | $36.1M | — | ||
| Q2 24 | $82.0M | $-55.4M | ||
| Q1 24 | $45.8M | — |
自由现金流ICUISAIL
| Q4 25 | $36.0M | $52.5M | ||
| Q3 25 | $27.6M | $49.0M | ||
| Q2 25 | $-8.5M | $-99.0M | ||
| Q1 25 | $36.7M | — | ||
| Q4 24 | $16.1M | — | ||
| Q3 24 | $16.2M | — | ||
| Q2 24 | $62.5M | $-56.0M | ||
| Q1 24 | $29.9M | — |
自由现金流率ICUISAIL
| Q4 25 | 6.6% | 18.6% | ||
| Q3 25 | 5.1% | 18.5% | ||
| Q2 25 | -1.5% | -43.0% | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 10.5% | -29.8% | ||
| Q1 24 | 5.3% | — |
资本支出强度ICUISAIL
| Q4 25 | 4.6% | 0.4% | ||
| Q3 25 | 5.4% | 0.4% | ||
| Q2 25 | 3.6% | 1.0% | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 3.3% | 0.3% | ||
| Q1 24 | 2.8% | — |
现金转化率ICUISAIL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
SAIL
| Software As A Service Saa S | $156.0M | 55% |
| Term Subscriptions Services | $65.1M | 23% |
| Maintenance | $38.0M | 13% |
| Other | $15.7M | 6% |
| Other Subscription Services | $7.1M | 3% |
